Oceanyx Pharmaceuticals

Oceanyx Pharmaceuticals

Oceanyx Pharmaceuticals, Inc. is an emerging pharmaceutical company that leverages marine cyanobacteria-based research for the discovery of novel drugs for the treatment of cancer, bone and neurodegenerative disorders.. Oceanyx drug candidates largazole and apratoxin S4, are being studied treatment of colorectal and breast cancer and potentially ophthalmic and/or bone disorders.

© 2012 Progress Corporate Park
Powered by trees, designed by Parisleaf